Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
871.3 DKK | +0.44% | +0.61% | +24.81% |
Apr. 15 | More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm | RE |
Apr. 15 | Biophytis: patent application filed in the field of obesity | CF |
Sales 2024 * | 287B 41.1B | Sales 2025 * | 346B 49.44B | Capitalization | 3,887B 556B |
---|---|---|---|---|---|
Net income 2024 * | 104B 14.82B | Net income 2025 * | 125B 17.9B | EV / Sales 2024 * | 13.6 x |
Net Debt 2024 * | 26.72B 3.82B | Net Debt 2025 * | 3.78B 541M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
37.7
x | P/E ratio 2025 * |
31
x | Employees | 63,845 |
Yield 2024 * |
1.38% | Yield 2025 * |
1.66% | Free-Float | 70.47% |
Latest transcript on Novo Nordisk A/S
1 day | +0.44% | ||
1 week | +1.59% | ||
Current month | -1.13% | ||
1 month | -3.62% | ||
3 months | +19.11% | ||
6 months | +23.26% | ||
Current year | +24.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 90-12-31 | |
Director of Finance/CFO | 53 | 98-12-31 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 63 | 15-03-18 |
Helge Lund
CHM | Chairman | 61 | 17-03-22 |
Martin MacKay
BRD | Director/Board Member | 68 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 192 M€ | +11.64% | ||
10.45% | 5 M€ | +6.38% | ||
5.40% | 18 M€ | +2.84% | - | |
4.67% | 88 M€ | +10.37% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 871.3 | +0.44% | 1,469,864 |
24-04-16 | 867.5 | -1.33% | 1,728,440 |
24-04-15 | 879.2 | -0.09% | 1,814,804 |
24-04-12 | 880 | +1.23% | 2,064,983 |
24-04-11 | 869.3 | +0.38% | 2,276,825 |
Delayed Quote Nasdaq Copenhagen, April 17, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.81% | 551B | |
+28.79% | 673B | |
-7.64% | 348B | |
+15.00% | 317B | |
+5.99% | 288B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 195B | |
-11.71% | 145B | |
-8.32% | 142B |
- Stock Market
- Equities
- NOVO B Stock